MAGTIDLIRA 33™ – Dual-Action Weight Loss Pen
(Semaglutide 3 mg + Tirzepatide 30 mg)
The Ultimate Synergy for Appetite Control, Fat Reduction & Metabolic OptimizationExperience the next evolution in GLP-1 therapy with MAGTIDLIRA 33™, a breakthrough dual-action injectable combining Semaglutide and Tirzepatide for unmatched weight-loss performance and metabolic balance.
This innovative formula delivers superior appetite suppression, accelerated fat loss, and sustained energy regulation—all in one powerful weekly injection.Dual-Agonist Power
Harnesses the combined action of GLP-1 and GIP-GLP-1 receptor activation to:
Enhance satiety and reduce cravings
Improve glucose control and metabolic efficiency
Support fat loss while preserving lean muscle
This unique synergy amplifies results beyond single-compound treatments.
Pre-Filled. Precision-Dosed. Ready to Use.
Each 3 ml sterile pen is pre-filled and equipped with 8 disposable needles for effortless self-injection.
Simply dial your dose and inject - no preparation, no mixing, no hassle.
){kind=link}